JASMINE GILL: Open Payments
NPI 1164747697 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 42 payments from 14 companies in 2025. Trend: 2023 $743 · 2024 $842 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Collegium Pharmaceutical, Inc. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Lundbeck LLC | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Tris Pharma Inc | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Corium, LLC | 2 | $40 |
Products named: VRAYLAR, COBENFY, REXULTI, Jornay PM, CAPLYTA, INGREZZA, Dyanavel XR, Qelbree.
Industry payments across PA — which companies pay providers there.
